患者中心の心臓血管臨床試験のエンドポイントの利用と解釈の拡大
Shelby D Reed1, Pishoy Gouda1,2
1Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Journal of clinical and translational science
|September 2, 2025
まとめ
新規の臨床試験のエンドポイントは,患者にとって重要なアウトカムを測定することで,患者中心性を改善します. これらの結果を組み合わせるには様々な方法がありますが,その影響を比較するにはさらなる研究が必要です.
科学分野:
- 臨床研究方法論
- 患者による報告結果
- 医療経済と成果の研究
背景:
- 臨床研究における患者中心化の強化は 臨床試験の結果と患者の価値観と経験の調和を図る上で極めて重要です
- 生存日と出院日 (DAOH) と生活の質に調整された結果などの新しい臨床試験のエンドポイントがますます利用されています.
- 患者にとって重要な出来事や好みを含む複合的なアウトカムにより,治療の効果の評価がより豊かになります.
研究 の 目的:
- 患者中心の臨床試験のエンドポイントの開発と利用を調査する.
- 患者中心の複合的な結果の構築と分析のニュアンスと方法論について議論する.
- 患者中心の結果分析の異なるアプローチに関する比較研究の必要性を強調する.
主な方法:
- 患者が報告した結果と経験に焦点を当てた新しい臨床試験のエンドポイントの方法論のレビュー
- イベントの選択,アウトカムの定義,および重力の誘導を含む複合的なアウトカムの構築の議論.
- 勝率,加重勝率,DOOR,MCDAなどの加重結果を組み合わせる分析方法の概要
主要な成果:
- 患者中心のエンドポイントは,患者の健康状態と日常生活に直接関連するアウトプットです.
- 複合的な結果アプローチは,複数の,順位付けされた,または加重されたイベントの統合を可能にします.
- 各種統計的方法 (Win ratio,DOOR,MCDA) が,患者中心の複合的なアウトカムを分析するために存在し,それぞれに特定の利点と課題があります.
結論:
- 臨床研究における患者中心の成果の改善は,患者,臨床医,および規制当局の重要な目標です.
- 総合的なアウトカムにおけるイベントの選択と加重は,患者の好みと臨床的関連性を慎重に考慮する必要があります.
- 患者中心の様々な結果分析方法の含意と最適の適用を理解するために,さらなる比較研究が必要である.
関連する概念動画
01:16Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
01:11Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34